ALK and glioblastoma: In four GBM cases with strong ALK (5A4) immunoreactivity, the FISH assay revealed no rearrangement or amplification of the ALK locus (Fig 3C), and none of the cases had any mutations in exons 20, 23, 24, and 25 of the ALK gene (S7 Fig).